Home LiteratureArticle Details
PMID: 7519245 Published · ppublish English Comparative Study Journal Article

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.

The Journal of experimental medicine ·Vol. 180 ·No. 2 ·1994-08-01 ·Pages 631-40

Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ

Abstract

Antigen-specific T cell activation requires the engagement of the T cell receptor (TCR) with antigen as well as the engagement of appropriate costimulatory molecules. The most extensively characterized pathway of costimulation has been that involving the interaction of CD28 and CTLA4 on the T cell with B7 (now termed B7-1) on antigen presenting cells. Recently, B7-2 a second costimulatory ligand for CTLA4, was described, demonstrating the potential complexity of costimulatory interactions. This report examines and compares the expression and function of B7-1 and B7-2. Overall these results indicate that (a) B7-1 and B7-2 can be expressed by multiple cell types, including B cells, T cells, macrophages, and dendritic cells, all of which are therefore candidate populations for delivering costimulatory signals mediated by these molecules; (b) stimulating B cells with either LPS or anti-IgD-dextran induced expression of both B7-1 and B7-2, and peak expression of both costimulatory molecules occurred after 18-42 h of culture. Expression of B7-2 on these B cell populations was significantly higher than expression of B7-1 at all times assayed after stimulation; (c) blocking of B7-2 costimulatory activity inhibited TCR-dependent T cell proliferation and cytokine production, without affecting early consequences of TCR signaling such as induction of CD69 or interleukin 2 receptor alpha (IL-2R alpha); and (d) expression of B7-1 and of B7-2 can be regulated by a variety of stimuli. Moreover, expression of B7-1 and B7-2 can be independently regulated by the same stimulus, providing an additional complexity in the mechanisms available for regulating costimulation and hence immune response.

MeSH Terms
Animals Antigens, CD/biosynthesis Antigens, Differentiation, T-Lymphocyte/biosynthesis B-Lymphocytes/immunology B7-1 Antigen/biosynthesis,immunology B7-2 Antigen Base Sequence CD28 Antigens/immunology CHO Cells Cells, Cultured Cricetinae Cytokines/biosynthesis DNA Female Lectins, C-Type Ligands Lymphocyte Activation Macrophage Activation Macrophages/immunology Membrane Glycoproteins Mice Mice, Inbred Strains Molecular Sequence Data Rabbits Receptors, Antigen, T-Cell/immunology Receptors, Interleukin-2/biosynthesis T-Lymphocytes/immunology,metabolism
Chemicals
Antigens, CD Antigens, Differentiation, T-Lymphocyte B7-1 Antigen B7-2 Antigen CD28 Antigens CD69 antigen Cd86 protein, mouse Cytokines Lectins, C-Type Ligands Membrane Glycoproteins Receptors, Antigen, T-Cell Receptors, Interleukin-2 DNA
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hathcock K S
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Laszlo G
Pucillo C
Linsley P
Hodes R J
References (52)
52 references, click to expand
  1. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11059-63 PMID: 7504293
  2. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11182-6 PMID: 7504299
  3. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.
    J Immunol. 1994 Jun 1;152(11):5208-19 PMID: 7514631
  4. Strong histocompatibility and cell-mediated cytotoxic effects of a single Mls difference demonstrated using a new congenic mouse strain.
    Eur J Immunol. 1983 Apr;13(4):292-300 PMID: 6221931
  5. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody.
    Eur J Immunol. 1979 Apr;9(4):301-6 PMID: 89034
  6. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.
    J Exp Med. 1979 Sep 19;150(3):580-96 PMID: 90108
  7. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    J Immunol. 1982 Feb;128(2):823-7 PMID: 6274961
  8. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis.
    Immunol Rev. 1982;68:135-69 PMID: 6184304
  9. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development.
    Immunol Rev. 1982;69:5-23 PMID: 6984001
  10. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    J Immunol. 1983 Jun;130(6):2534-41 PMID: 6222106
  11. The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.
    J Immunol. 1984 Oct;133(4):1970-5 PMID: 6206144
  12. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    J Exp Med. 1986 Mar 1;163(3):603-19 PMID: 2936862
  13. Identification of a monoclonal antibody specific for a murine T3 polypeptide.
    Proc Natl Acad Sci U S A. 1987 Mar;84(5):1374-8 PMID: 2950524
  14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  15. B7, a B-cell-restricted antigen that identifies preactivated B cells.
    J Immunol. 1987 Nov 15;139(10):3260-7 PMID: 3500211
  16. Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation.
    J Immunol. 1988 May 15;140(10):3364-72 PMID: 2452184
  17. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation.
    J Immunol. 1988 Jul 15;141(2):369-76 PMID: 2838547
  18. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
    Proc Natl Acad Sci U S A. 1989 Feb;86(4):1333-7 PMID: 2465550
  19. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.
    Science. 1989 Apr 21;244(4902):339-43 PMID: 2540528
  20. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.
    Annu Rev Immunol. 1989;7:445-80 PMID: 2653373
  21. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.
    J Immunol. 1989 Oct 15;143(8):2714-22 PMID: 2794510
  22. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
    Proc Natl Acad Sci U S A. 1990 Jul;87(13):5031-5 PMID: 2164219
  23. Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice.
    Proc Natl Acad Sci U S A. 1990 Sep;87(18):7135-9 PMID: 2402496
  24. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate.
    J Immunol. 1990 Dec 1;145(11):3618-27 PMID: 2246506
  25. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.
    Science. 1991 Jan 18;251(4991):313-6 PMID: 1846244
  26. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
    J Exp Med. 1991 Mar 1;173(3):721-30 PMID: 1847722
  27. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
    J Exp Med. 1991 Mar 1;173(3):759-62 PMID: 1847724
  28. CTLA-4 is a second receptor for the B cell activation antigen B7.
    J Exp Med. 1991 Sep 1;174(3):561-9 PMID: 1714933
  29. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.
    J Exp Med. 1991 Sep 1;174(3):625-31 PMID: 1714935
  30. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.
    J Immunol. 1991 Oct 1;147(7):2391-7 PMID: 1717559
  31. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):271-5 PMID: 1370349
  32. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.
    Nature. 1992 Apr 16;356(6370):607-9 PMID: 1313950
  33. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells.
    Proc Natl Acad Sci U S A. 1992 May 1;89(9):4210-4 PMID: 1373896
  34. Identification and distribution of the costimulatory receptor CD28 in the mouse.
    J Immunol. 1992 Jul 15;149(2):380-8 PMID: 1320641
  35. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
    J Clin Invest. 1992 Jul;90(1):229-37 PMID: 1378854
  36. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.
    Science. 1992 Aug 7;257(5071):789-92 PMID: 1323143
  37. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.
    Science. 1992 Aug 7;257(5071):792-5 PMID: 1496399
  38. CD45 expression by B cells. Expression of different CD45 isoforms by subpopulations of activated B cells.
    J Immunol. 1992 Oct 1;149(7):2286-94 PMID: 1388188
  39. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.
    J Exp Med. 1992 Oct 1;176(4):1215-20 PMID: 1328465
  40. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.
    Nature. 1992 Nov 19;360(6401):266-8 PMID: 1279442
  41. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    J Exp Med. 1992 Dec 1;176(6):1595-604 PMID: 1334116
  42. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
    Eur J Immunol. 1993 Jan;23(1):295-8 PMID: 7678229
  43. Functional expression of B7/BB1 on activated T lymphocytes.
    J Exp Med. 1993 Mar 1;177(3):845-50 PMID: 7679711
  44. In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study.
    Int Immunol. 1993 Mar;5(3):317-21 PMID: 7682106
  45. The role of the CD28 receptor during T cell responses to antigen.
    Annu Rev Immunol. 1993;11:191-212 PMID: 8386518
  46. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.
    J Immunol. 1993 Aug 1;151(3):1224-34 PMID: 7687627
  47. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
    J Exp Med. 1993 Nov 1;178(5):1789-93 PMID: 8228824
  48. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation.
    Science. 1993 Nov 5;262(5135):905-7 PMID: 7694361
  49. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
    Science. 1993 Nov 5;262(5135):907-9 PMID: 7694362
  50. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Science. 1993 Nov 5;262(5135):909-11 PMID: 7694363
  51. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
    J Exp Med. 1993 Dec 1;178(6):2185-92 PMID: 7504059
  52. Expression and functional significance of an additional ligand for CTLA-4.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11054-8 PMID: 7504292
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1994-08-01
Pages
631-40
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2191623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com